Literature DB >> 16571074

Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities.

Nicholas R Forsyth1, Antonio Musio, Paolo Vezzoni, A Hamish R W Simpson, Brendon S Noble, Jim McWhir.   

Abstract

Human embryonic stem cells (hESC) have great potential in regenerative medicine, provided that culture systems are established that maintain genomic integrity. Here we describe a comparison of the effects of culture in either physiologic oxygen (2%) or room oxygen (21%) on the hESC lines, H1, H9, and RH1. Physiologic oxygen enabled an average sixfold increase in clone recovery across the hESC lines tested (p < 0.001). FACS analysis showed that cells cultured in physiologic oxygen were significantly smaller and less granular. No significant changes had occurred in levels of SSEA4, SSEA1, TRA-1-60, or TRA-1-81. While karyotypic normalcy was maintained in both H1 and H9, the frequency of spontaneous chromosomal aberrations was significantly increased in room oxygen. This increase was not observed in physiologic oxygen. These results clearly demonstrate that physiologic oxygen culture conditions are indispensable for robust hES clone recovery and may enhance the isolation of novel hES lines and transgenic clones.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571074     DOI: 10.1089/clo.2006.8.16

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  59 in total

Review 1.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

2.  Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells.

Authors:  Li Li; Bill H Wang; Shuai Wang; Lilian Moalim-Nour; Kanishka Mohib; David Lohnes; Lisheng Wang
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

3.  Importance of culturing primary lymphocytes at physiological oxygen levels.

Authors:  Kondala R Atkuri; Leonard A Herzenberg; Anna-Kaisa Niemi; Tina Cowan; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

4.  Simultaneous reprogramming and gene editing of human fibroblasts.

Authors:  Sara E Howden; James A Thomson; Melissa H Little
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

Review 5.  Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.

Authors:  Daniel E Kehoe; Donghui Jing; Lye T Lock; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

Review 6.  Advances in cell culture: anchorage dependence.

Authors:  Otto-Wilhelm Merten
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

7.  Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells.

Authors:  Suzanne D Westfall; Shrikesh Sachdev; Padmalaya Das; Leonard B Hearne; Mark Hannink; R Michael Roberts; Toshihiko Ezashi
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

8.  Induction of stem cell gene expression in adult human fibroblasts without transgenes.

Authors:  Raymond L Page; Sakthikumar Ambady; William F Holmes; Lucy Vilner; Denis Kole; Olga Kashpur; Victoria Huntress; Ina Vojtic; Holly Whitton; Tanja Dominko
Journal:  Cloning Stem Cells       Date:  2009-09

9.  Derivation and cloning of a novel rhesus embryonic stem cell line stably expressing tau-green fluorescent protein.

Authors:  Florence Wianny; Agnieszka Bernat; Cyril Huissoud; Guillaume Marcy; Suzy Markossian; Véronique Cortay; Pascale Giroud; Vincent Leviel; Henry Kennedy; Pierre Savatier; Colette Dehay
Journal:  Stem Cells       Date:  2008-03-20       Impact factor: 6.277

10.  Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions.

Authors:  Catherine E Forristal; Kate L Wright; Neil A Hanley; Richard O C Oreffo; Franchesca D Houghton
Journal:  Reproduction       Date:  2010-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.